Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 11:52 PM
Ignite Modification Date:
2025-12-25 @ 9:47 PM
NCT ID:
NCT01373151
Group ID:
EG003
Title:
Clazakizumab(100)+MTX
Description:
BMS-945429 + Methotrexate + Adalimumab Placebo
BMS-945429: Injection, Subcutaneous, 25 mg, Every 4 weeks, Day 1 - Week 24 only
BMS-945429: Injection, Subcutaneous, 200 mg, Every 4 weeks, Week 25 - Week 48
Methotrexate: Tablets, Oral, 15 mg, Weekly, 48 weeks
Adalimumab Placebo: Injection, Subcutaneous, 0 mg, Every 2 weeks, 48 weeks
Deaths Number Affected:
0
Deaths Number At Risk:
None
Serious Number Affected:
5
Serious Number At Risk:
60
Other Number Affected:
51
Other Number At Risk:
60
Study:
NCT01373151
Results Section:
NCT01373151
Adverse Events Module:
NCT01373151